• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Aspects of the role of intraglomerular pressure as a cause of progressive renal damage.

作者信息

Aurell M

机构信息

Department of Nephrology, Sahlgrenska Hospital, University of Göteborg.

出版信息

Drugs. 1988;35 Suppl 5:42-7. doi: 10.2165/00003495-198800355-00007.

DOI:10.2165/00003495-198800355-00007
PMID:3063484
Abstract

Renal damage in hypertension was thought to be a result of excessive renal arteriolar constriction leading to ischaemia and nephron damage. However, more recent studies have shown that in animal models the aetiology is one of increased intraglomerular pressure, and there is strong evidence that this is also the case in patients with essential hypertension. The problem is therefore one of inadequate constriction of afferent arterioles allowing increased systemic pressure to be transmitted to the glomerular capillaries. Since angiotensin II preferentially constricts the efferent arterioles, and since hypertensive patients have increased renovascular sensitivity to angiotensin II, this may explain why angiotensin-converting enzyme inhibitors are the only drugs which actually lower intraglomerular pressure and why they reduce renal damage in hypertensive disease.

摘要

相似文献

1
Aspects of the role of intraglomerular pressure as a cause of progressive renal damage.
Drugs. 1988;35 Suppl 5:42-7. doi: 10.2165/00003495-198800355-00007.
2
[Are all antihypertensive drugs renoprotective?].[所有抗高血压药物都具有肾脏保护作用吗?]
Herz. 2004 May;29(3):248-54. doi: 10.1007/s00059-003-2508-6.
3
Possible mechanism for the renoprotective effect of angiotensin converting enzyme inhibitors.
J Hypertens Suppl. 1989 Sep;7(7):S33-6; discussion S36-7. doi: 10.1097/00004872-198909007-00007.
4
[Therapeutic strategy for progressive renal disease].[进展性肾病的治疗策略]
Nihon Rinsho. 2001 May;59(5):955-60.
5
Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.在L-NAME/SHR模型中,噻嗪类药物与血管紧张素转换酶抑制剂或AT1受体阻滞剂联合使用在肾脏保护方面优于单独使用噻嗪类药物。
Am J Physiol Renal Physiol. 2005 Oct;289(4):F871-9. doi: 10.1152/ajprenal.00129.2005. Epub 2005 May 17.
6
Influence of anti-hypertensive drugs on glomerular hemodynamics.抗高血压药物对肾小球血流动力学的影响。
Nihon Jinzo Gakkai Shi. 1996 Mar;38(3):115-8.
7
Angiotensin-converting enzyme inhibitors in chronic renal failure.慢性肾衰竭中的血管紧张素转换酶抑制剂
Drugs. 1990;39 Suppl 2:23-32. doi: 10.2165/00003495-199000392-00006.
8
Pathophysiology of hypertensive renal damage.高血压肾损害的病理生理学
Am J Hypertens. 1993 Jul;6(7 Pt 2):241S-244S. doi: 10.1093/ajh/6.7.241s.
9
Treatment of hypertension in renal disease.肾病高血压的治疗。
Am J Kidney Dis. 1985 Apr;5(4):A57-70. doi: 10.1016/s0272-6386(85)80067-6.
10
Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension.钙拮抗剂对出球小动脉作用的角色——特别涉及肾小球高血压
Am J Nephrol. 2003 Jul-Aug;23(4):229-44. doi: 10.1159/000072054. Epub 2003 Jul 1.

引用本文的文献

1
Sodium Glucose Co-Transporter 2 Inhibitors and the Cardiovascular System: Current Knowledge and Future Expectations.钠-葡萄糖协同转运蛋白2抑制剂与心血管系统:当前认识与未来展望
Heart Int. 2023 Dec 1;17(2):12-18. doi: 10.17925/HI.2023.17.2.12. eCollection 2023.
2
C-Peptide: the missing link in diabetic nephropathy?C肽:糖尿病肾病中缺失的环节?
Rev Diabet Stud. 2009 Fall;6(3):203-10. doi: 10.1900/RDS.2009.6.203. Epub 2009 Nov 10.

本文引用的文献

1
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation.残余肾单位的超滤:对肾切除的一种潜在不良反应。
Am J Physiol. 1981 Jul;241(1):F85-93. doi: 10.1152/ajprenal.1981.241.1.F85.
2
Blood pressure in relation to the renin-angiotensin-aldosterone system.与肾素-血管紧张素-醛固酮系统相关的血压
Acta Med Scand. 1982;211(5):351-60. doi: 10.1111/j.0954-6820.1982.tb01961.x.
3
Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.
膳食蛋白质摄入量与肾脏疾病的进展特性:血流动力学介导的肾小球损伤在衰老、肾切除及原发性肾脏疾病所致进行性肾小球硬化发病机制中的作用
N Engl J Med. 1982 Sep 9;307(11):652-9. doi: 10.1056/NEJM198209093071104.
4
Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels.去甲肾上腺素和血管紧张素II对离体肾微血管的节段性作用。
Am J Physiol. 1983 May;244(5):F526-34. doi: 10.1152/ajprenal.1983.244.5.F526.
5
Characterization of glomerular permeability and proteinuria in acute hypertension in the rat.大鼠急性高血压时肾小球通透性和蛋白尿的特征
Kidney Int. 1984 Apr;25(4):599-607. doi: 10.1038/ki.1984.63.
6
Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.低于升压剂量的血管紧张素II对肾血流动力学与血压关系的影响。
Hypertension. 1983 May-Jun;5(3):368-74. doi: 10.1161/01.hyp.5.3.368.
7
Renal response in man to plasma volume expansion and angiotensin.人体对血容量扩充和血管紧张素的肾脏反应。
Scand J Clin Lab Invest Suppl. 1969;112:1-59.
8
Effect of captopril on heavy proteinuria in azotemic diabetics.卡托普利对氮质血症糖尿病患者重度蛋白尿的影响。
N Engl J Med. 1985 Dec 26;313(26):1617-20. doi: 10.1056/NEJM198512263132601.
9
Evidence against increased glomerular pressure initiating diabetic nephropathy.
Kidney Int. 1987 Apr;31(4):898-905. doi: 10.1038/ki.1987.83.
10
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.卡托普利对胰岛素依赖型糖尿病肾病患者肾功能的影响。
Br Med J (Clin Res Ed). 1986 Aug 23;293(6545):467-70. doi: 10.1136/bmj.293.6545.467.